Related Experiment Videos
Infantile epileptic syndromes and metabolic etiologies
Federico Vigevano1, Andrea Bartuli
1Division of Neurology, Bambino Gesù Children's Hospital, Rome, Italy. vigevano@opbg.net
Insights
Inherited metabolic disorders are a key cause of early-onset epilepsy, often presenting with varied neurological symptoms beyond seizures. Early diagnosis is crucial for managing these complex conditions.
Area of Science:
- Neurology
- Metabolic Disorders
- Epileptology
Background:
- Inherited metabolic disorders (IMDs) are a significant cause of epilepsy in infants.
- Epilepsy is often not the primary symptom, with other neurological issues like developmental delay being more prominent.
- The mechanisms of seizures in IMDs are diverse, involving neurotransmitter imbalance, energy deficits, or brain malformations.
Purpose of the Study:
- To highlight the crucial role of IMDs in early-onset epilepsy.
- To discuss the varied clinical presentations and diagnostic challenges.
- To emphasize the need for considering IMDs in epilepsy cases with neurological decline.
Main Methods:
- Review of clinical presentations and electroencephalogram (EEG) findings in epilepsy secondary to IMDs.
- Analysis of established and emerging etiological pathways for seizures in IMDs.
- Correlation of specific clinical signs with particular metabolic causes.
Main Results:
- While some IMDs have characteristic epilepsy syndromes (e.g., pyridoxine-dependent seizures), most present with diverse and difficult-to-classify clinical and EEG features.
- Common seizure characteristics include early onset, partial and multifocal seizures, and resistance to standard antiepilepsy drugs.
- Specific clinical clues can suggest certain metabolic etiologies.
Conclusions:
- IMDs should be strongly considered in infants with epilepsy, especially when accompanied by progressive neurological worsening.
- Recognizing specific clinical and EEG patterns can aid in identifying certain metabolic causes.
- A comprehensive approach is needed for diagnosing and managing epilepsy in the context of IMDs.
Abstract:
Inherited metabolic disorders can cause onset of epilepsy in the first year of life. Epilepsy rarely dominates the clinical presentation, which is more frequently associated with other neurologic symptoms, such as mental retardation, hypotonia and/or dystonia, or vigilance disturbances. The pathogenesis of seizures is multifaceted; inherited metabolic disorder can affect the balance between excitatory and inhibitory chemical mediators, eliminate an energetic substrate at the cerebral level, cause in utero brain malformation, or provoke acute brain lesions. Some clinical disorders that strongly suggest particular metabolic etiologies can be identified. For example, specific clinical signs and findings on electroencephalogram (EEG) are characteristic of pyridoxine-dependent seizures, and inherited metabolic disorders associated with early myoclonic encephalopathy are well defined. In most cases, however, epilepsy secondary to inherited metabolic disorders presents with polymorphic clinical and EEG features that are difficult to classify into precise epileptic syndromes. Common characteristics of these seizures include onset in the first months of life; usually partial, multifocal; simple partial motor semiology; successive appearance of tonic seizures, spasms, and massive myoclonus; and resistance to antiepilepsy drugs. Inherited metabolic disorders must be considered in patients presenting with epilepsy and progressive neurologic worsening.